Sriam Labs

India Updated 9 July 2026

Sriam Labs is an API manufacturer based in India. It appears in 2 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

active US DMFs

valid CEPs

registered plants

filings across 1 regulators

What they file, and where

Molecule	Regulators	Docs
Labetalol	SFDA (Saudi Arabia)	1

Also appears on these molecule pages

Labetalol API

Filings and GMP by regulator

Regulator	Filings	GMP certificates
CDSCO (India)	2	None

Questions about Sriam Labs

Does Sriam Labs hold a US DMF or a CEP?

No active US drug master file or valid CEP is on record for Sriam Labs. It does have 2 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.

What does Sriam Labs make?

1 molecule is on record against Sriam Labs, including Labetalol. Each links through to that molecule's full manufacturer list.

Where does Sriam Labs file?

Filings are on record with CDSCO (India), 2 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Sriam Labs comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Comparable suppliers

Alivus Life Sciences shares 1 molecule Olon shares 1 molecule Zydus Lifesciences shares 1 molecule Macleods Pharmaceuticals shares 1 molecule Neuland Laboratories shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability